QNRX Stock Summary and Trading Ideas (Quoin Pharmaceuticals Ltd. - American Depositary Shares | NASDAQ:QNRX)

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.

As of August 21, 2026, QNRX stock price climbed to $5.57 with 71,751 million shares trading.

QNRX has a beta of -1.23, meaning it tends to be less sensitive to market movements. QNRX has a correlation of 0.01 to the broad based SPY ETF.

QNRX has a market cap of $11.19 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNRX traded as high as $236.60 and as low as $3.25.

QNRX has underperformed the market in the last year with a return of -21.1%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in QNRX shares. However, QNRX has outperformed the market in the last 3 month and 2 week periods, returning +12.8% and +21.9%, while SPY returned +3.6% and -0.4%, respectively. This indicates QNRX has been having a stronger performance recently.

QNRX support price is $4.69 and resistance is $5.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.